Sumitovant Biopharma, Sumitomo Pharma and Myovant Sciences close…
Sumitovant Biopharma acquires all outstanding shares of Myovant for $27 per share in cash The combination provides expertise and resources to address unmet patient needs
Home » Sumitovant
Sumitovant Biopharma acquires all outstanding shares of Myovant for $27 per share in cash The combination provides expertise and resources to address unmet patient needs
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within